RSS feed - Pivot Park

Synaffix Announces Expansion of ADC Collaboration with MacroGenics
Source: Pivot Park News Published on 2023-03-14
The third edition of the Surviving the Dutch program has started!
Source: Pivot Park News Published on 2023-03-08
Pivot Park Screening Center has Assay Development Fund available for early drug discovery project
Source: Pivot Park News Published on 2023-02-28
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
Source: Pivot Park News Published on 2023-02-24
Reaching big heights at Pivot Park
Source: Pivot Park News Published on 2023-02-16
New Oncolines publication in Cancers
Source: Pivot Park News Published on 2023-02-13
Leaders in Life Sciences – #10 Pieter van der Meer
Source: Pivot Park News Published on 2023-02-08
Get to know: Pedersen & Partners
Source: Pivot Park News Published on 2023-02-02
Leaders in Life Sciences – #9 Bernard Mulder
Source: Pivot Park News Published on 2023-01-17
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
Source: Pivot Park News Published on 2023-01-16
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
Source: Pivot Park News Published on 2023-01-16
10 years Pivot Park: Pivot Park
Source: Pivot Park News Published on 2023-01-16
10 years Pivot Park: Pivot Park
Source: Pivot Park News Published on 2023-01-16
10 years Pivot Park: Pivot Park
Source: Pivot Park News Published on 2023-01-16
10 years Pivot Park: Nelisca
Source: Pivot Park News Published on 2023-01-05

Looking for
space to grow?

More information

Learn about
our companies?

Send us a message

or call

+31 (0)412 84 60 10

Disclaimer | Privacy Policy | Purchase conditions

Address

Pivot Park –
Building RK
Kloosterstraat 9
5349 AB Oss
The Netherlands
+31 (0)412 – 84 60 10
info@pivotpark.com

Post address

Pivot Park Exploitatie B.V.
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands